Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
DOI: 10.1056/NEJMoa1402584 [Google Scholar] Wollin L, Distler JHW, Redente EF, Riches DWH, Stowasser S, Schlenker-Herceg R, et al
The introduction of a subcutaneous formulation, approved in September 2023, offered patients a more convenient administration option compared to the traditional intravenous infusion, enhancing its competitiveness against similar therapies like Novartis Kesimpta
The activation of the NLRP3 inflammasome mediates the cleavage of caspase-1 and the secretion of the IL-1 proinflammatory cytokine, ultimately inducing cell death through a process known as pyroptosis
However, MNTI occasionally manifests as higher-density lesions with clearer boundaries between surrounding tissues
